Dexamethasone in Tick-borne Encephalitis
Recruiting
Phase 3
Interventional Study
Tick-Borne Encephalitis
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 200 (estimated)
- Sponsor
- University Medical Centre Ljubljana · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to investigate the efficacy of dexamethasone in patients with tick-borne encephalitis.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* age 18 years or older and
* clinical signs and symptoms of meningoencephalitis or meningomyelitis and
* cerebrospinal pleocytosis and
* serological confirfmation of tick-borne encephalitis virus infection
Exclusion Criteria:
* pregnancy or
* severe neurological impairment be…
Contacts